Trastuzumab
compare suppliers & send inquiries for free
Filters
Reset
Selected filters:
Type
Region
Qualifications
Country of origin
Producer
Produced in:
Established in: 2019
MOQ: 1 g
Employees: 10+

Focused on pharmaceutical industry

Reasonable price for the customers

Full service from R&D stage to commercial stage
+ 0
All certificates
Send inquiry
Replies quickly
Send inquiry
Replies slower than most
How does it work?
You can register for free as long as you are registering on behalf of a legal company related to the pharmaceutical industry
Search in the search bar the product that you’re looking for. We’ll show you an overview of all available suppliers. Use the filters to select the relevant suppliers only
Have you found interesting suppliers? Then it’s time to contact them. Use the send inquiry button and send them a message. You can send for each product, 3 inquiries per week
Suppliers get notified by Pharmaoffer that they’ve received a new inquiry. They will come back to you with their questions, certificates, and offer in the chat on Pharmaoffer. We will send you an email in case of any news
Does the supplier meet your quality and commercial requirements? Then you can place the order. Just follow the steps of our order module
Send inquiry
Replies slower than most
Producer

Fermentation technology Experts

Partnerships with 1200 pharma companies in 100+ countries

US FDA, EMA, COFEPRIES, ANVISA, PMDA accreditations
+ 0
All certificates
Send inquiry
Replies quickly
Looking for Trastuzumab 180288-69-1?
- API | Excipient name:
- Trastuzumab
- Synonyms:
- Cas Number:
- 180288-69-1
- DrugBank number:
- DB00072
- Unique Ingredient Identifier:
- P188ANX8CK
About Trastuzumab
So, what does it do? Produced in CHO cell cultures, trastuzumab is a recombinant IgG1 kappa, humanized monoclonal antibody 6 that selectively binds with high affinity in a cell-based assay (Kd = 5 nM) to the extracellular domain of the human epidermal growth factor receptor protein (HER2). It is used as a treatment of human epidermal growth factor receptor (HER)-2+ metastatic breast cancer, where there is a proven amplification of the HER-2 oncogene or over-expression of the HER-2 protein in tumours. It is suggested that the overexpression or gene amplification of HER2 has been found in about 20–30% of breast cancers and elevated activation of HER2 triggers multiple downstream pathways leading to abnormal proliferation of cancer cells Trastuzumab binds to HER2 and suppresses cancer cells growth, proliferation, and survival directly and indirectly In December 2017, FDA approved Ogivri (trastuzumab-dkst) as a biosimilar to Herceptin (trastuzumab) for the treatment of patients with breast or metastatic stomach cancer (gastric or gastroesophageal junction adenocarcinoma) whose tumors overexpress the HER2 gene (HER2+). It displays biosimilar properties as Herceptin according to clinical data.
While Ogivri is the first biosimilar approved in the USA for the treatment of breast cancer or stomach cancer, it is the second biosimilar approved in the USA for the treatment of cancer. Herzuma (trastuzumab-pkrb) is a biosimilar drug approved in December 2018 for the treatment of HER2-overexpressing breast cancer. KANJINTI (trastuzumab-anns) is another biosimilar approved by the FDA in June 2019.
You can ask the supplier about all relevant certificates for the product such as CoA, Safety Data Sheet and DMF.
Trastuzumab manufacturers | traders | suppliers
We have 4 companies offering Trastuzumab from 4 different countries.
Get in contact with the supplier of your choice:
- Apino Pharma Co., Ltd. from China
- Sandoz from Austria
- Celltrion from South Korea
- Biocon from India
Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.
You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.